Pathophysiology and diagnosis of male erectile dysfunction

BJU International, Supplement

Volumn 88, Issue 3, 2001, Pages 3-10

  Wagner, G ^a   Mulhall, J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NICOTINIC ACID; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BRAIN REGION; BRAIN STEM; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE COURSE; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; ERECTILE DYSFUNCTION; HISTORY OF MEDICINE; HUMAN; PATHOPHYSIOLOGY; PENIS ERECTION; PERIPHERAL NERVE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SPINAL CORD;

AGED; HUMANS; IMPOTENCE; LIFE STYLE; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PENILE ERECTION; PHYSICAL EXAMINATION; RISK FACTORS;

EID: 0034787140     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.122.x     Document Type: Article

References (65)

1. NIH Consensus Conference: Impotence
2. Clinical review. Update on male erectile dysfunction
3. The epidemiology and pathophysiology of erectile dysfunction
4. Erectile dysfunction in the aging man
5. Impotence and its medical and psychosocial correlates. Results of the Massachusetts Male Aging Study
6. Erection: Anatomy
7. Vascular physiology of penile erection
8. Neurophysiology of penile erection
9. Central control of erection and its pharmacological modification
10. The reproductive systems
11. Stimulation of the medial preoptic area of the hypothalamus in the rat elicits increases in intracavernous pressure
12. Opposite influence of medial preoptic D1 and D2 receptors on genital reflexes: Implications for copulation
13. Medial preoptic and hypothalamic neuronal activity during sexual behaviour of the male monkey
14. Inhibitory effect of 5-hydroxytryptamine on penile erectile function in the rat
15. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes
16. 2c receptors on spinal neurons controlling penile erection in the rat
17. Physiology of penile erection
18. Microscopic anatomy of the penis
19. Sildenafil: A selective phosphodiesterase (PDE) 5 inhibitor in the treatment of erectile dysfunction (ED)
20. Role of nitric oxide in the physiology of erection
21. Comparative tolerability and efficacy of treatments for impotence
22. Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells
23. Effects of some peptides on isolated human penile erectile tissue and cavernous artery
24. Comparison of responses to drugs acting on adrenoceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery
25. Modulation of adrenergic activity in penile corpus cavernosum
26. Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips
27. Pharmacological studies of human erectile tissue: Characteristic of spontaneous contractions and alteration in α-adrenoceptor responsiveness with age and disease in isolated tissues
28. Anatomy, physiology and pathophysiology of erectile dysfunction
29. Impotence and aging: Clinical and hormonal factors
30. Risk factors for impotence
31. Autonomic dysfunction in men with Parkinson's disease
32. Erectile dysfunction in multiple sclerosis
33. Impotence following radical prostatectomy: Insight into etiology and prevention
34. Neurological disorders: Erectile and ejaculatory dysfunction
35. Testosterone and prolactin. Behavioural and psychophysiological approaches in men
36. Testosterone in impotent men
37. Plasma prolactin, FSH, LH and testosterone in 71 patients with sexual disturbance
38. The hypothalamic-pituitary-testicular axis in thyrotoxicosis
39. Abnormal testicular function in men with primary hypothyroidism
40. Hyperprolactinemia and impotence: Why, when and how to investigate
41. Suppressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apomorphine to pituitary-transplanted rats
42. Diagnostic evaluation of erectile dysfunction
43. Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner
44. Erectile dysfunction. Its diagnosis and treatment
45. Recommendations of the 1st International Consultation on Erectile Dysfunction
46. Clinical evaluation and the doctor-patient dialogue
47. Discrimination between psychogenic and organic erectile dysfunction
48. Iatrogenic erectile dysfunction: Pharmacological and surgical therapies that alter male sexual behaviour and erectile performance
49. Symptom score and quality of life
50. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction
51. Development and evaluation of an abridged, 5-item, version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction
52. A comparison of patient and partner responses to a brief sexual function questionnaire
53. Impact of erectile dysfunction on quality of life: Patient and partner perspectives
54. Erectile dysfunction: A practical approach for primary care
55. Evaluation and nonsurgical management of erectile dysfunction and priapism
56. Venous incompetence in erectile dysfunction: Evaluation with color-coded duplex sonography and cavernosometry/cavernosography
57. The role of nocturnal penile tumescence monitoring in the diagnosis of impotence: A review
58. The role of nocturnal penile tumescence and rigidity monitoring in the evaluation of impotence
59. Erotic erection versus nocturnal erection
60. Nocturnal penile tumescence and rigidity monitoring for the evaluation of erectile dysfunction
61. Reversible loss of nocturnal penile tumescence during depression: A preliminary report
62. Nocturnal penile tumescence in depressed men
63. Problems in the interpretation of nocturnal penile tumescence studies: Disruption of sleep by occult sleep disorders
64. Theoretical and technical problems in the measurement of nocturnal penile tumescence for the differential diagnosis of impotence
65. Healthy aging and male sexual function